|
NFIL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.39349999994653E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43729999999109E-05 |
| Normal-vs-Stage2 |
2.164800E-03 |
| Normal-vs-Stage3 |
2.37049999999295E-05 |
| Normal-vs-Stage4 |
7.791200E-04 |
| Stage1-vs-Stage2 |
8.340000E-01 |
| Stage1-vs-Stage3 |
3.892600E-01 |
| Stage1-vs-Stage4 |
9.755200E-01 |
| Stage2-vs-Stage3 |
7.594000E-01 |
| Stage2-vs-Stage4 |
8.850200E-01 |
| Stage3-vs-Stage4 |
5.588200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.49289999999914E-05 |
| Normal-vs-AfricanAmerican |
3.069600E-02 |
| Normal-vs-Asian |
6.585900E-04 |
| Caucasian-vs-AfricanAmerican |
8.887200E-01 |
| Caucasian-vs-Asian |
3.776800E-01 |
| AfricanAmerican-vs-Asian |
5.228200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78856999999422E-05 |
| Normal-vs-Female |
4.01979999997693E-06 |
| Male-vs-Female |
2.226600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.448400E-04 |
| Normal-vs-Age(41-60Yrs) |
2.83850000004637E-06 |
| Normal-vs-Age(61-80Yrs) |
6.32919999965509E-07 |
| Normal-vs-Age(81-100Yrs) |
8.455400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.384200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.147700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.909800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.802300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.309000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.974200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.154800E-01 |
| Classical-VS-Follicular |
1.691770E-02 |
| Classical-VS-Other |
9.941000E-01 |
| Classical-VS-Normal |
5.78759999999567E-05 |
| Tall-VS-Follicular |
1.311410E-01 |
| Tall-VS-Other |
9.542600E-01 |
| Tall-VS-Normal |
1.426390E-02 |
| Follicular-VS-Other |
4.227600E-01 |
| Follicular-VS-Normal |
3.85590000040459E-07 |
| Other-VS-Normal |
1.306360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.85169999953072E-07 |
| Normal-vs-N1 |
1.7663899999909E-05 |
| N0-vs-N1 |
9.832800E-01 |
|
|
